Dose Track reminds you to take Saxenda every day, logs each shot with its site, and counts the milligrams left in your 18 mg pen as the dose rises. The weekly steps from 0.6 mg to 3 mg are recorded from the day each one starts.
Per the FDA label, Saxenda starts at 0.6 mg once daily for week 1, then rises weekly: 1.2 mg in week 2, 1.8 mg in week 3, 2.4 mg in week 4, and 3 mg daily from week 5 onward. For adults, 3 mg is the label's recommended dose; the lower doses are for titration only (2.2, Table 1).
| When | Dose on the label | Label note |
|---|---|---|
| Week 1 | 0.6 mg once daily | Starting dose; the label says lower dosages are for titration only in adults |
| Week 2 | 1.2 mg once daily | |
| Week 3 | 1.8 mg once daily | |
| Week 4 | 2.4 mg once daily | |
| Week 5 and onward | 3 mg once daily | Recommended (and maximum) dose |
Saxenda is the only GLP-1 here that steps up every week, so the dose changes four times in the first month. Recording each change from its date in Dose Track keeps the pen count right, because a 3 mg day uses five times what a 0.6 mg day does.
Each Saxenda pen holds 18 mg of liraglutide in 3 mL and you dial the dose. How long a pen lasts depends on your dose, which is why Dose Track counts the pen in mg rather than shots.
| Product | What it delivers | Pack sizes | Contents |
|---|---|---|---|
| Saxenda prefilled pen (single-patient-use, multi-dose) | Dial-a-dose: 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg, or 3 mg per injection | Cartons of 3 pens or 5 pens | 18 mg liraglutide in 3 mL (6 mg/mL) |
Each row is something worth writing down for Saxenda, why it matters for this medicine, and what Dose Track does with it.
| What to track | Why it matters | In Dose Track |
|---|---|---|
| Daily dose | The label gives Saxenda once daily at any time of day, without regard to meals (2.1). | A daily reminder at your time; log in one tap. |
| Weekly steps | 0.6 mg in week 1, then 1.2, 1.8, 2.4 and 3 mg from week 5 (2.2, Table 1). | Record each new dose from the day it starts; the history shows every step. |
| mg left in the pen | One pen is 18 mg (6 mg/mL), so it lasts 6 days at 3 mg and much longer on the first steps (3, 16). | Dose Track has the Saxenda pen from the label and subtracts each logged dose, so you see how much is left and when to open the next pen. |
| Injection site | Abdomen, thigh or upper arm, rotated within the same region (2.1). | Each shot is logged with its site; the next one is suggested. |
| Weight | Saxenda is labeled for weight reduction with diet and physical activity. | Log weight or sync it from Apple Health or Health Connect. |
| Side effects | Nausea, diarrhea, constipation and vomiting were the most common reactions in the label's trials (6.1). | Quick picks for GLP-1 side effects with severity, against your step. |
| Reaction | Placebo (N=1941) | Saxenda (N=3384) |
|---|---|---|
| Nausea | 13.8% | 39.3% |
| Diarrhea | 9.9% | 20.9% |
| Constipation | 8.5% | 19.4% |
| Vomiting | 3.9% | 15.7% |
| Injection site reaction | 10.5% | 13.9% |
| Headache | 12.6% | 13.6% |
| Hypoglycemia in type 2 diabetes (blood glucose <54 mg/dL; Study 2 only) | 6.6% | 12.6% |
| Dyspepsia | 2.7% | 9.6% |
| Fatigue | 4.6% | 7.5% |
| Dizziness | 5% | 6.9% |
| Abdominal pain | 3.1% | 5.4% |
| Increased lipase | 2.2% | 5.3% |
| Upper abdominal pain | 2.7% | 5.1% |
| Gastroenteritis | 3.2% | 4.7% |
| Gastroesophageal reflux disease | 1.7% | 4.7% |
| Abdominal distension | 3% | 4.5% |
| Eructation | 0.2% | 4.5% |
| Urinary tract infection | 3.1% | 4.3% |
| Flatulence | 2.5% | 4% |
| Viral gastroenteritis | 1.6% | 2.8% |
| Insomnia | 1.7% | 2.4% |
| Dry mouth | 1% | 2.3% |
| Asthenia | 0.8% | 2.1% |
| Anxiety | 1.6% | 2% |
The label reports that the percentage of adults reporting nausea declined as treatment continued, and that asthenia, fatigue, malaise, dysgeusia and dizziness were mainly reported within the first 12 weeks, often alongside GI events (6.1). In the adult trials, 9.8% on Saxenda vs 4.3% on placebo stopped treatment because of adverse reactions (6.1).
Dose Track has quick picks for the side effects people on GLP-1 medicines log most: nausea, constipation, diarrhea, reflux or heartburn, tiredness, low appetite, injection-site reaction and headache. You can type in anything else, set how bad it was, and see it next to the dose and the dose step you were on.
Saxenda side effects from the FDA label
Per the label, a missed dose is not made up: the once-daily regimen resumes with the next scheduled dose, with no extra or increased dose. If more than 3 days have passed since the last dose, the label says to restart at 0.6 mg daily and follow the Table 1 escalation again. (2.1) Missed a Saxenda dose.
In Dose Track a missed dose stands out in your history, so you can see the gap and count from the right day.
Dose Track is a tracking app, not medical advice. It records what you and your prescriber decide; it does not recommend doses. Check any dose change with your prescriber.
Sources: the FDA label for Saxenda (liraglutide), revised 6/2026; numbers in brackets are label section numbers. Read on DailyMed or the guides linked above; app features checked against the current app.
All GLP-1 trackers · All medication trackers · Supported medications · Help center